Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion type Assertion NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_head.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion description "[We show here, using in vitro receptor autoradiography, a NPY receptor incidence of 85% in primary human breast carcinomas (n = 95) and of 100% in lymph node metastases of receptor-positive primaries (n = 27), predominantly as Y(1) subtype, whereas non-neoplastic human breast expressed Y(2) preferentially.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_provenance.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion evidence source_evidence_literature NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_provenance.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion SIO_000772 11389101 NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_provenance.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion wasDerivedFrom befree-20140225 NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_provenance.
- NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_assertion wasGeneratedBy ECO_0000203 NP671958.RAd7vUadHzLCRM2i2Bdd1S-uUjPzn5CeO9bf0Mzbp1PK0130_provenance.